Iranian Journal of Psychiatry and Behavioral Sciences

Aims and scope: The Iranian Journal of Psychiatry and Behavioral Sciences (IJPBS) is an international quarterly peer review journal which is aimed to promote communication among researchers worldwide and welcomes contributions from authors in all areas of psychiatry, psychology and behavioral sciences. The journal publishes original contributions that have not previously been submitted for publication elsewhere. Manuscripts are received with the understanding that they are submitted solely to the IJPBS. Upon submission, they become the property of the Publisher and that the data in the manuscript have been reviewed by all authors, who agree with the analysis of the data and the conclusions reached in the manuscript. The Publisher reserves copyright and renewal on all published material and such material may not be reproduced without the written permission of the Publisher. Statements in articles are the responsibility of the authors. Peer-Review: Manuscripts are first reviewed by the editorial staff to ensure their appropriateness relevant to the framework of the journal. Manuscripts are also excluded by the editors if there are major faults in the methodology of research. Peer reviews are handled anonymously and comments are discussed in editorial sessions. Reviews are then sent to the corresponding authors for proposed modifications and the new version of the manuscript would be peer-reviewed for a second time by external reviewers. Online Submission: Manuscripts must be created in Microsoft Word (Microsoft Word files with .docx extension are not accepted and should be converted to .doc before submitting). For further information please contact the editorial office through: Tel: +98 11 33285659 or +98 11 33262679 Fax: +98 11 33285659 The requirements stated below are in accordance with the International Committee of Medical Journal Editors. (See Uniform Requirements for Manuscripts Submitted to Biomedical Journals.) Covering letter: Papers are accepted for publication in the journal on the understanding that the content has not been published or submitted for publication elsewhere. This must be stated in the covering letter. Authors must also state that the protocol for the research conforms to the provisions of the Declaration of Helsinki in 1995 (as revised in Edinburgh 2000). Authors should declare any financial support or relationships that may pose conflict of interest by disclosing at the time of submission. Categories of publication: The following types of articles will be considered for publication: The following types of articles will be considered for publication: (1)Original articles: Reports of original studies related to all issues of psychiatry, psychology and behavioral sciences that are well documented, novel, and significant. These articles should not exceed 5,500 words; have a total of 6 or fewer tables and figures, an abstract of 250 words or less. (2) Review article, Systematic review and meta analysis:Reviews of the literature on a topic that is relevant to the content of this journal may be considered. The review must be evidence-based and provide an unbiased discussion of relevant literature. Authors should include a description of how the literature was selected and assessed. Discussion of controversial or unresolved issues and their importance for the medical community is appropriate. They should not exceed 6,500 words of text with 5 or fewer tables and figures, an abstract of 250 words, and 100 or fewer references. (3)Short communication: Short descriptions of novel approaches to mental health problems or creative applications of established concepts in different settings. Advances should be 3,000 words long and no more than a total of 4 tables or figures, with an abstract of no more than 150 words. (4)Brief report: Brief, definitive reports of highly significant and timely findings. Advances should be 3,000 words long, with an abstract of no more than 150 words, an abbreviated Introduction, Materials and Methods section, Results and Discussion sections (which may be combined) and no more than a total of 4 tables or figures. (5) Commentary: Commentaries are brief manuscripts that advance the knowledge base of the readers by addressing an important topic related to a topic that is relevant to the content of this journal. They are generally not related to a specific article that was published in a previous journal issue. Commentaries should have a specific focus and be supported by literature citations. (6)Case report:This should be reports of genuine rare cases limited to no more than 1500 words comprising of a short introduction, case report and discussion followed by references of no more than 20. Limit the abstract to approximately 100 words. If colour figures and photos are absolutely necessary for the report, they should be original or of high quality. (7)Letters to the Editor:In the spirit of open scientific dialogue, the Editor-in-Chief invites the submission of correspondence that presents considered opinions in response to articles published in the journal. Letters to the Editor will be reviewed and, if found to meet the requisite publication criteria, may be sent to the author(s) of the originally published article and possibly to other interested parties for a response to be published in the same issue of the journal as the Letter. Letters should have a brief title that references the topic of the originating article, and Letters should not exceed 400 words, with 5 or fewer references and no tables or figures. (8) Editorials: Editorials are usually commissioned by the Editor-in-Chie for Associate Section Editors, but the Editor-in-Chief will consider potential editorials from authors who would like to contribute. Clinical Trial Registration: IJPBS requires that randomized controlled trials be registered according to policies accepted by International Committee of Medical Journal Editors,World Association of Medical Editors (WAME), and Iranian Committee of Medical Journal Editors (ICMJE). In order to be considered for publication, trials that begin enrolment of patients after December 22nd 2009 must register in a public trials registry at or before the onset of enrolment, and trials that began patient enrolment on or before this date must register anytime before submission to the journal. The registration number of the trial and the name of the trial registry must be mentioned at the end of the abstract. Recommended trial registries include the following: Manuscript Preparation: Language:Manuscripts should be written in clear, American English. The past tense should be used throughout in describing the results and the present tense in referring to previously established and generally accepted results. Authors who are unsure of correct English usage should have their manuscript checked by somebody who is proficient in the language; manuscripts that are deficient in this respect may be returned to the author for revision before scientific review. Title: Write a brief and informative title that identifies the nature of the subject matter. Avoid chemical formulas or abbreviations. Title page:The title page should include: (a) the full title of the article (b) the authors' full names (first name, middle initial, surname) with degrees and status in the institute; (c) affiliations, institution, city, and state or country where the work was done; (d) acknowledgments of grant support of the study; (e) the name and full address of corresponding author indicated by a star (as well as telephone and facsimile numbers, e-mail address, and if available URL address); (f) running title (approximately 30 spaces); and (g) authors’ contributions. Authorship contributions: IJPBS adheres to the guidelines on authorship established by the ICMJE statement on Authorship and Contribution. According to these guidelines, authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Authors should meet all of these three conditions. Entering patients for study or providing funding or administrative oversight are not sufficient for authorship; instead these contributions should appear in the Acknowledgment section. If someone other than the authors, such as a science writer or corporate employee, has participated in writing the paper, this participation must be disclosed. If a multicenter group conducted the research, the group should identify a writing committee that accepts direct responsibility for the manuscript. Authors themselves, not IJPBS, are responsible for settling any disputes about authorship. Corresponding authors are responsible for ensuring that all authors have reviewed and approved the final version of the manuscript prior to submission. Abbreviations:Only common abbreviations may be used without definition. Terms appearing frequently (three or more times) within a paper may be abbreviated, but should be spelled out at first citation, with the abbreviation following in parentheses. Pejorative Language: Do not use pejorative labels like "schizophrenics", "psychotics" and "neurotics". Instead refer to "patients with schizophrenia", etc. Abstract:This should not be more than 250 words and should state purpose of the study, basic procedures, most important findings, and principal conclusions. Original articles must use the following headings: Objective, Methods, Results, Conclusion, and Declaration of interest. Write the abstract in third person. References should not be cited and abbreviations should be avoided. Keywords: A list of three to five keywords should be included below the abstract in alphabetical order, and should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MESH) browser list. If suitable MESH terms are not yet available for recently introduced terms, present terms may be used. Original articles must use the following headings: Introduction: This should contain a description of the problem under investigation and relevant background information and published studies should be described concisely, and be cited appropriately. Materials and Methods:The methods, apparatus and procedures should be identified in sufficient details. Avoid redescribing methods frequently cited before; only relevant modifications should be included in the text. For experiments on humans, indicate whether the procedures followed were in accord with the standards of the ethics Committee of the institution in which the experiments were done. For drugs the generic name should be used. Trade names may appear in parentheses and should be capitalized. Results: This section should include the findings of the study. Data should not be repeated in both a Table and a Figure. Discussion:It should relate the results to previous works and interpret them not a simple recapitulate of the Results. Authors’ Contributions: Those with substantial intellectual contributions who meet the ICMJE criteria on authorship should be included as an author. Authors should submit information about the contributions of each person who has participated in the study. Acknowledgments: This optional part should include a statement thanking those who assisted substantially with work relevant to the study. Grant support should be included in this section. References: References should be numbered consecutively in the order in which they are first mentioned in the text. Identify references in text, tables, and legends by Arabic numerals in parentheses. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. Use the style of the examples below, which are based on the formats used by the NLM in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Consult the List of Journals Indexed in Index Medicus, published annually as a separate publication by the library and as a list in the January issue of Index Medicus. The list can also be obtained through the library's web site ( References to papers or books accepted but not yet published should be designated as "in press"; authors should obtain written permission to cite such papers as well as verification that they have been accepted for publication. Information from manuscripts submitted but not accepted should be cited in the text as "unpublished observations" with written permission from the source. Avoid citing a "personal communication" unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. For scientific articles, authors should obtain written permission and confirmation of accuracy from the source of a personal communication. Articles in Journals 1. Standardjournalarticle List the first six authors followed by et al. Zinbarg RE, Barlow DH, Liebowitz M, Street L, Broadhead E, Katon W, et al. The DSM-IV field trial for mixed anxiety-depression.Am J Psychiatry 1994; 151:1153-62. 2. Organization as author The Cardiac Society of Australia and New Zealand. Clinical exercise stress testing. Safety and perfor-mance guidelines.Med J Aust 1996; 164: 282-4. 3. No author given Cancer in South Africa [editorial]. S Afr Med J 1994; 84: 15. 4. Article not in English (Note: Translate the title to English, enclose the translation in square brackets, and add an abbreviated language designator.) Zarghami M, Khalilian AR. [Epidemiology of committing suicide in Kordkouy.] Pejouhandeh 2003-04; 8(5): 361-70. Persian. 5. Volume with supplement Shen HM, Zhang QF. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 1994; 102(Suppl 1): 275-82. 6. Issue with supplement Payne DK, Sullivan MD, Massie MJ. Women's psychological reactions to breast cancer. Semin Oncol 1996; 23(1 Suppl 2): 89-97. 7. Volume with part Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995; 32(Pt 3): 303-6. 8. Issue with part Poole GH, Mills SM.One hundred consecutive cases of flap lacerations of the leg in ageing patients. N Z Med J 1994; 107(986 Pt 1): 377-8. 9. Issue with no volume Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop 1995; (320): 110-4. 10. No issue or volume Browell DA, Lennard TW. Immunologic status of the cancer patient and the effects of blood transfusion on antitumor responses. Curr Opin Gen Surg 1993: 325-33. 11. Pagination in Roman numerals Fisher GA, Sikic BI. Drug resistance in clinical oncology and hematology.Introduction. Hematol Oncol Clin North Am 1995 Apr; 9(2): xi-xii. 12. Type of article indicated as needed Enzensberger W, Fischer PA. Metronome in Parkinson's disease [letter]. Lancet 1996;347:1337. Clement J, De Bock R. Hematological complications of hantavirus nephropathy (HVN) [abstract]. Kidney Int 1992; 42: 1285. 13. Article containing retraction Garey CE, Schwarzman AL, Rise ML, Seyfried TN. Ceruloplasmin gene defect associated with epilepsy in EL mice [retraction of Garey CE, Schwarzman AL, Rise ML, Seyfried TN. In: Nat Genet 1994; 6: 426-31]. Nat Genet 1995; 11: 104. 14. Article retracted Liou GI, Wang M, Matragoon S. Precocious IRBP gene expression during mouse development [retracted in Invest Ophthalmol Vis Sci 1994; 35: 3127]. Invest Ophthalmol Vis Sci 1994; 35: 1083-8. 15. Article with published erratum Hamlin JA, Kahn AM. Herniography in symptomatic patients following inguinal hernia repair [published erratum appears in West J Med 1995; 162: 278]. West J Med1995; 162: 28-31. Books and Other Monographs 16. Personal author(s) Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996. 17. Editor(s), compiler(s) as author Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996. 18. Organization as author and publisher Institute of Medicine (US).Looking at the future of the Medicaid program. Washington: The Institute; 1992. 19. Chapter in a book Mojtabai R. Acute and transient psychotic disorders and brief psychotic disorder.In: Sadock BJ, MD and Sadock VA, MD editors. Kaplan and Sadock's Comprehensive textbook of psychiatry. Philadelphia: Lippincott Williams and Wilkins; 2005. Vol. 2. p. 1512-22. 20. Conference proceedings Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam: Elsevier; 1996. 21. Conference paper Bengtsson S, Solheim BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92.Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland. Amsterdam: North-Holland; 1992. p. 1561-5. 22. Scientific or technical report Issued by funding/sponsoring agency: Smith P, Golladay K. Payment for durable medical equipment billed during skilled nursing facility stays.Final report. Dallas (TX): Dept. of Health and Human Services (US), Office of Evaluation and Inspections; 1994 Oct. Report No.: HHSIGOEI69200860. Issued by performing agency: Field MJ, Tranquada RE, Feasley JC, editors. Health services research: work force and educational issues. Washington: National Academy Press; 1995. Contract No.: AHCPR282942008. Sponsored by the Agency for Health Care Policy and Research. 23. Dissertation Kaplan SJ. Post-hospital home health care: the elderly's access and utilization [dissertation]. St. Louis (MO): Washington Univ.; 1995. 24.Patent Larsen CE, Trip R, Johnson CR, inventors; Novoste Corporation, assignee. Methods for procedures related to the electrophysiology of the heart. US patent 5,529,067. 1995 Jun 25. Other Published Material 25.Newspaper article Lee G. Hospitalizations tied to ozone pollution: study estimates 50,000 admissions annually. The Washington Post 1996 Jun 21; Sect. A: 3 (col. 5). 26. Audiovisual material HIV+/AIDS: the facts and the future [videocassette]. St. Louis (MO): Mosby-Year Book; 1995. 27. Legal material Public law: Preventive Health Amendments of 1993, Pub. L. No. 103-183, 107 Stat. 2226 (Dec. 14, 1993). Unenacted bill: Medical Records Confidentiality Act of 1995, S. 1360, 104th Cong., 1st Sess. (1995). Code of Federal Regulations: Informed Consent, 42 C.F.R. Sect. 441.257 (1995). 28. Hearing: Increased Drug Abuse: the Impact on the Nation's Emergency Rooms: Hearings Before the Subcomm. on Human Resources and Intergovernmental Relations of the House Comm. on Government Operations, 103rd Cong., 1st Sess. (May 26, 1993). 29. Map North Carolina. Tuberculosis rates per 100,000 population, 1990 [demographic map]. Raleigh: North Carolina Dept. of Environment, Health, and Natural Resources, Div. of Epidemiology; 1991. 30. Book of the Qur'an, Bible, etc. The Holy Qur'an: Text, translation and commentary. By T.B. Irving (Al-Hajj Ta'lim Ali). Tehran: Suhrawardi Research and Publication Center; 2003. Chapter 2, Verse 195; p.30. The Holy Bible. King James version. Grand Rapids (MI): Zondervan Publishing House; 1995. Ruth 3:1-18. 31. Dictionary and similar references Stedman's medical dictionary. 26th ed. Baltimore: Williams & Wilkins; 1995. Apraxia; p. 119-20. 32. Classical material The Winter's Tale: act 5, scene 1, lines 13-16. The complete works of William Shakespeare. London: Rex; 1973. 33.Unpublished Material Leshner AI. Molecular mechanisms of cocaine addiction.N Engl J Med.In press 1996. Abdolmaleky HM, Smith CL, Zhou RJ, Thiagalingam S. Chapter 24. In: Fatemi SH editor. Reelin Glycoprotein, biology, structure and roles in health and disease.New York: Springer; In press2008. p. 365-84. Electronic Material 34. Journal article in electronic format Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5];1(1):[24 screens]. Available from: URL: 35. Monograph in electronic format CDI, clinical dermatology illustrated [monograph on CD-ROM]. Reeves JRT, Maibach H. CMEA Multimedia Group, producers.2nd ed. Version 2.0. San Diego: CMEA; 1995. 36. Computer file Hemodynamics III: the ups and downs of hemodynamics [computer program]. Version 2.2. Orlando (FL): Computerized Educational Systems; 1993. Tables:Tables should be so constructed that they, together with their captions and legends, will be intelligible with minimal reference to the text. They should be numbered (1, 2, 3, etc.) as they appear in the text. Vertical lines should not be used to separate columns of the tables. Column headings should be brief, with units of measurement in parentheses; all abbreviations should be defined in footnoted. Footnote symbols: †, ‡, §, ||, ¶, ††, ‡‡, should be used (in that order) and *, **, *** should be reserved for p-values. Figures: All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. Figures should be sized to fit within the column (69 mm), intermediate (100) or the full text width (144). Line figures should be supplied as sharp, black and white graphs or diagrams, drawn with a computer graphic package; lettering should be included. Graphics should be supplied as high resolution (at least 300 d.p.i.) files, saved as .eps or .tif format. Figure legends: Figure legends should be self-explanatory. The legend should incorporate definitions of any symbols used and all abbreviations and units of measurement should be explained so that the figure and its legend are understandable with minimal reference to the text. Provide a letter stating copyright authorization if figures have been reproduced from another source. Reprints:Ten reprints will be provided only to the corresponding author free of charge. Additional copies can be ordered at prices shown on the reprint order form. Revision:Papers may be returned to authors for modification of the scientific content and/or for shortening and language corrections. Revised versions must be submitted to the Editor and must be accompanied by a letter listing the changes that have been made. Suggestions by the Editors about resubmission do not imply that a revised version will necessarily be accepted. If a paper that is returned to the authors for modification is not resubmitted within two months it will be regarded as having been withdrawn and any revised version received subsequently will be treated as a new paper. Proofs:Proofs will be sent to the corresponding author to be checked for only typographical errors and other essential small changes. Major alterations to the text can not be accepted at this stage. No changes in the name of the authors are permissible at this stage. Proofs must be returned to the Editor within 7 days of receipt. After a manuscript has been accepted for publication and after all revisions have been incorporated, manuscripts should be submitted to the editor’s office. Copyright: upon acceptance of a manuscript for publication, authors will be asked to transfer copyright of the article to the IJPBS.

Write the security code in the box    
View: 16585 Time(s)   |   Print: 1062 Time(s)   |   Email: 117 Time(s)   |   0 Comment(s)

© 2018 All Rights Reserved | Iranian Journal of Psychiatry and Behavioral Sciences

Designed & Developed by : Yektaweb